3rd Quarter - Report

QUADRIPOINT STRATEGIES LLC for AMBIO

Period 3rd Quarter 2019 Filed Oct 22, 2019 Signed by David Crane

Official filing
Firm
QUADRIPOINT STRATEGIES LLC
Client
AMBIO
Income
$15,750
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

FDA regulation of generic insulin and peptide-based insulin products

LobbyistCovered position, as disclosed
DAVID CRANE Senior Policy Advisor, Majority Leader/Republican Leader Trent Lott, Professional Staff, Senate Commerce Committee, Chairman John McCain, LA/LD Senator Dan Coats

Contacted: SENATE; Office of the Vice President of the United States; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; White House Office

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.